Quality of Life in Men Treated for Androgenetic Alopecia via a Virtual Healthcare Platform: A Retrospective Cohort Study
December 2025
Studysummary This study found that treating androgenetic alopecia through a virtual healthcare platform significantly improved hair-loss-related quality of life over six months, with adherence to the program being a key factor in achieving better outcomes among the participants in Brazil.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This study evaluated the impact of treating androgenetic alopecia (AGA) through a virtual healthcare platform on the quality of life (QoL) of men in Brazil over six months. Using a 16-item hair-specific questionnaire, the study found that the mean QoL score improved significantly from 73.07 to 60.78, indicating better QoL (p < 0.001). Adherence to the treatment program was the strongest predictor of improvement, with fully engaged participants experiencing nearly double the QoL gain compared to those with interrupted engagement (p < 0.001). Additionally, lower baseline QoL and older age were linked to greater improvements, while medication potency was not a significant factor. The study concludes that digital care models can significantly enhance hair-loss-related QoL, highlighting the importance of adherence strategies in optimizing patient outcomes.
